ImmunoGen Reports Recent Progress and 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall Street closes lower as oil prices jump, indexes notch monthly gains
- The Warsh pivot markets didn't expect
- Oil settles up by more than 2.5% as US and Iran resume military attacks
- Energy stocks rally as fresh U.S.-Iran attacks drive oil prices higher
- BofA turns S&P 500 signals from red to yellow: What to buy now
Immunogen (IMGN) Tops Q4 EPS by 26c, Offers Q1 Guidance
February 12, 2021 6:32 AM ESTImmunogen (NASDAQ: IMGN) reported Q4 EPS of $0.16, $0.26 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $85.8 million versus the consensus estimate of $37.09 million.
GUIDANCE:
Immunogen sees Q1 2021 revenue of $65-75 million, versus the consensus of $53.1... More
